Document is current

Article History

Accepted: 19 April 2024

First Online: 9 May 2024

Competing interests

: K.M. reports consulting fees from Chinook and funds to her department for being a site principal investigator for a study sponsored by Vertex outside the submitted work. K.N.C. reports consulting fees from Travere, Goldfinch, Chinook, ANI, Sanofi, and Aurinia and funds to his department for being a site principal investigator for studies sponsored by Vertex, Chinook and Travere outside the submitted work. J.C.H. reports consulting fees from Yingli Pharmaceutics and serves as founder of Rila Therapeutics and member of the Scientific Advisory Board for Renalytix.